Sean Ianchulev
NEW ORLEANS — Phacoemulsification has improved since its introduction 50 years ago, but further advances are possible, a speaker here said.
At the American Academy of Ophthalmology meeting, Sean Ianchulev, MD, gave results of a first-in-human feasibility study of 101 grade 3 and higher cataractous eyes randomized to the miLOOP (Iantech) plus phacoemulsification or phacoemulsification alone.
“Fifty-three percent higher phaco energy was used in the phaco-alone group vs. the microinterventional group, so it really made the phaco more efficient,” Ianchulev said. “There
Uncategorized